Patricia Dorling
Senior Director, Value & Implementation, Outcomes Research Merck & Co
Seminars
Monday 27th October 2025
9:00 Strategies to Streamline Collaboration, Accelerate Decision Making & Improve Real-World Evidence Acceptance Across Pharma, Regulators & Payers
Navigating payer and regulatory requirements in RWE is a high-stakes challenge, one missed step can mean delays, denied coverage, or wasted data. Regulators demand rigor, payers prioritize cost-effectiveness, yet their definitions of “acceptable evidence” rarely align. With evolving guidelines and increasing scrutiny, how can pharma generate the right data to bridge this gap?
- Unpack real-world case studies on where pharma, regulators, and payers are misaligned, and the subsequent impact
- Discuss examples of RWE-driven approvals and reimbursements that have worked, and why
- Develop practical steps to ensure RWE meets the needs of all stakeholders
Tuesday 28th October 2025
1:40 Integrating Real-World Evidence into Health Technology Assessments to Address Data Gaps & Drive Market Access Success
- Standardize RWE data collection and reporting methods to reduce inconsistencies and improve the credibility of submissions to HTA bodies
- Use RWE to supplement clinical trial data, providing a more comprehensive view of a treatment’s real-world effectiveness, safety, and cost-effectiveness
- Foster collaboration between clinical, regulatory, and market access teams to ensure RWE aligns with HTA criteria and accelerates market access decisions
